Trade Summary

2 days ago, Stout Jay S, serving as Chief Technology Officer at Immunovant, Inc. (IMVT), sold 40,000 shares at $38.31 per share, for a total transaction value of $1,532,309.48. Following this transaction, Stout Jay S now holds 211,685 shares of IMVT.

This sale represents a 15.89% decrease in Stout Jay S's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, June 26, 2026 and publicly disclosed via SEC Form 4 filing on Friday, June 26, 2026 at 7:45 PM ET, meaning the disclosure happened on the same day as the trade.

Immunovant, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.